Where Can I Buy NeoFipronis (Miaite)
Neofipronis (Pronidesivir) GS-441524 is a groundbreaking oral medication specifically designed for treating Feline Infectious Peritonitis (FIP). FIP is a severe and often fatal disease in cats, characterized by symptoms such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomas, neurological damage, and uveitis. NeoFipronis offers a promising solution with proven efficacy against the FIP virus, providing hope for cat owners worldwide.
Neofipronis (Pronidesivir) is the first antiviral drug officially approved in Laos by the Ministry of Agriculture and Forestry (MAF) in March 2026. Its registration number confirms its status as a safe and effective pharmaceutical product. As a highly absorbed, non-invasive, and fast-acting treatment, NeoFipronis demonstrates excellent tolerance with minimal side effects. Its active component, GS-441524, has undergone extensive research and clinical validation, establishing itself as a potent antiviral agent against FIP.
This medication is administered orally, with dosing tailored to the cat's weight. The standard dosage is 15 mg per kilogram of body weight, roughly equivalent to half a pill. For neurological or ocular FIP forms, dosage may be increased under veterinarian supervision to 30 mg/kg. Administer once daily, preferably on an empty stomach—either one hour before meals or two hours after—to maximize absorption. Treatment must continue for a minimum of 12 weeks, with strict adherence to dosing schedules to prevent resistance or relapse. Missing doses should be avoided, and regular monitoring of the cat's appetite, temperature, behavior, and overall health is essential.
During treatment, veterinarians recommend periodic blood tests to assess liver and kidney function, ensuring the cat’s safety. While NeoFipronis is available as an over-the-counter product in some regions, it is strongly advised to use the medication under veterinary guidance to ensure proper dosing and monitor for potential adverse effects. Consulting with a veterinarian familiar with feline infectious diseases can optimize treatment outcomes.
The safety profile of NeoFipronis makes it suitable even for long-term use, and its minimal side effects include transient gastrointestinal discomfort in some cats. Importantly, NeoFipronis is intended strictly for feline use and should never be administered to humans. To guarantee product authenticity and quality, purchase NeoFipronis (Pronidesivir) exclusively through official websites or authorized veterinary suppliers. When buying online, verify the legitimacy of the source to avoid counterfeit medications, which can be ineffective or dangerous.
In summary, NeoFipronis (Pronidesivir) GS-441524 represents a revolutionary advancement in the fight against FIP in cats. Its proven efficacy, ease of oral administration, and strong safety profile make it a favored choice among veterinary professionals and cat owners. By sourcing NeoFipronis from reputable suppliers and following veterinary guidance, pet owners can provide their cats with the best chance for recovery from this devastating disease.
For safe and reliable purchase options, visit the official NeoFipronis website or authorized veterinary pharmacies. Always seek professional veterinary advice before starting treatment to ensure the correct dosage and treatment duration. NeoFipronis offers new hope for cats affected by FIP, combining cutting-edge science with practical application to improve feline health worldwide.
